Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines ; volume:15 ; number:1 ; day:17 ; month:11 ; year:2017 ; pages:1-23 ; date:12.2017
Journal of nanobiotechnology ; 15, Heft 1 (17.11.2017), 1-23, 12.2017
- Klassifikation
-
Technische Chemie
- Urheber
-
De Serrano, Luis O.
- Beteiligte Personen und Organisationen
-
Burkhart, David J.
SpringerLink (Online service)
- DOI
-
10.1186/s12951-017-0319-9
- URN
-
urn:nbn:de:1111-201801195352
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- De Serrano, Luis O.
- Burkhart, David J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Studies on the skin penetration mechanisms of liposomal formulations
Development of prophylactic vaccines against HIV-1
Prophylactic and therapeutic DNA vaccines against Chagas disease
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Prophylactic vaccines for patients with human papillomavirus diseases (HPV)
Liposomal formulations for the oral delivery of the pharmaceutically active peptide exenatide
Long term cellular immune response to prophylactic human papillomavirus (HPV) vaccines
Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
Development and in vitro testing of liposomal gadolinium-formulations for neutron capture therapy of glioblastoma multiforme
Studies on the skin penetration mechanisms of liposomal formulations
Development of prophylactic vaccines against HIV-1
Prophylactic and therapeutic DNA vaccines against Chagas disease
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Prophylactic vaccines for patients with human papillomavirus diseases (HPV)
Liposomal formulations for the oral delivery of the pharmaceutically active peptide exenatide
Long term cellular immune response to prophylactic human papillomavirus (HPV) vaccines
Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
Development and in vitro testing of liposomal gadolinium-formulations for neutron capture therapy of glioblastoma multiforme
Studies on the skin penetration mechanisms of liposomal formulations
Development of prophylactic vaccines against HIV-1
Prophylactic and therapeutic DNA vaccines against Chagas disease
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Prophylactic vaccines for patients with human papillomavirus diseases (HPV)
Liposomal formulations for the oral delivery of the pharmaceutically active peptide exenatide
Long term cellular immune response to prophylactic human papillomavirus (HPV) vaccines
Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis